Therefore, our study aimed to evaluate the PD-L1 and JAK2 mRNA expression in molecularly defined ET patients, dependently from the disease phase, to answer the question of the mutual relation between the PD-L1mRNA and JAK2 mRNA expression and disease progression to post-ET- MF. Here, JAK2 is linked to essential thrombocythemia.